• 12 Hits
  • Search Condition : Filter (MeSH = Neovascularization, Pathologic / drug therapy*)
Species Resource Title
Human and Animal Cells SK-MEL-28(RCB1930) Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
Human and Animal Cells HuH-6(RCB1367) Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
Human and Animal Cells Colon-26(RCB2657) Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
Human and Animal Cells SAS(RCB1974) Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Human and Animal Cells OS-RC-2(RCB0735) Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.
Human and Animal Cells TE-1(RCB1894) Angiotensin-I converting enzyme inhibitors suppress angiogenesis and growth of esophageal carcinoma xenografts.
Human and Animal Cells YAC-1(RCB1165) Anti-tumor actions of major component 3'-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation.
Human and Animal Cells Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models.
Human and Animal Cells BALB/3T3 clone A31(RCB0005) Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity.
Human and Animal Cells NIH3T3 , LLC(RCB0558) , Jyg-MC HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Human and Animal Cells A431(RCB0202) , HL60(RCB0041) Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay.
Human and Animal Cells RCN-9(RCB0511) JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.